The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial

BACKGROUND: REPRIEVE, the Randomized Trial to Prevent Vascular Events in HIV, is a multicenter, primary prevention trial evaluating whether a statin can prevent major cardiovascular events in people with HIV. REPRIEVE is conducted at >100 clinical research sites (CRSs) globally. Detailed, compreh...

Descripción completa

Detalles Bibliográficos
Autores principales: Fulda, Evelynne S., Fichtenbaum, Carl J., Kileel, Emma M., Zanni, Markella V., Aberg, Judith A., Malvestutto, Carlos, Cardoso, Sandra Wagner, Berzins, Baiba, Lira, Rita, Harden, Regina, Robbins, Gregory, Martinez, Maria, Nieves, Sylvia Davila, McCallum, Sara, Cruz, Jorge Leon, Umbleja, Triin, Sprenger, Heather, Giguel, Francoise, Bone, Frederic, Wood, Ken, Byroads, Mark, Paradis, Kayla, Lu, Michael T., Douglas, Pamela S., Ribaudo, Heather J., Grinspoon, Steven K., Fitch, Kathleen V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891172/
https://www.ncbi.nlm.nih.gov/pubmed/36462699
http://dx.doi.org/10.1016/j.cct.2022.107035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891172/
https://www.ncbi.nlm.nih.gov/pubmed/36462699
http://dx.doi.org/10.1016/j.cct.2022.107035

Ejemplares similares